Comparisons of treatment outcome measures from initial evaluation to discharge were made based on pre- to postvalues for the total group, and for each individual group using paired t-test analyses with SPSS 13.0. Changes in self reported ratings of vertigo intensity were analyzed via Wilcoxin signed ranks test for ordinal data.
Effectiveness of treatment was determined by partial or complete resolution of symptoms. Complete resolution of symptoms was operationally defined as the subjective report of the abolishment of symptoms (0/10 intensity level of vertigo), along with a negative Dix-Hallpike, and no positive special tests or positions reproducing symptoms. Partial resolution of symptoms was operationally defined as a decrease in overall vertigo intensity level, with reduced number of positive positions, and reduced response to Dix-Hallpike from pretest to posttest. Patients who experienced complete or partial symptom resolution were considered to have a positive treatment outcome. No resolution of symptoms was defined as no change in vertigo intensity level, or in the number of positive symptom provoking positions, or response to Dix-Hallpike. Worsening of symptoms was indicated by an increase in vertigo intensity level, in conjunction with the continued positive Dix-Hallpike and/or increased number of positive positions.
Analysis of individual treatment outcomes measures for patients revealed that both groups experienced significant improvement from pretest to posttest, with a decreased number of symptom provoking special tests or positions, and a reduction of vertigo intensity ratings (Table 3). Significance level for data analysis was set at p < .05 (2 tailed). For the total group, fewer special tests provoked symptoms posttreatment with means as follows: .89 pre and .22 post (t(73)=5.36). There also were significantly fewer symptom provoking position changes: 2.86 pre and .70 post (t(72)=7.66). Wilcoxin signed ranks test revealed a significant reduction in ratings of vertigo intensity post treatment with a mean of 5.88 pre and 2.02 post (T=12.5; p < .05).
Analysis of treatment outcomes by group revealed that for the first outcome measure, patients receiving 24 hour instructions (n = 66) had fewer symptom provoking special tests with a means of .69 pre and .14 post (t(63)=5.24). Likewise, patients receiving 48 hour posttreatment instructions (n = 10) had fewer symptom provoking special tests, with a mean of 2.71 pre and 1.00 post (t(6)=2.29). For the second outcome measure, the 24 hour group had fewer symptom provoking positions, with a mean of 2.38 pre and .25 post (t(63)=9.76). The 48 hour group also had fewer symptom provoking positions with a mean of 6.33 pre and 3.89 post (t(8)=1.37; p = .21) but this difference was not significant (Table 3). For the final outcome measure, Wilcoxin signed ranks test revealed a significant reduction in vertigo intensity ratings for posttreatment patients with 24 hour instructions, with a mean of 5.71 pre and 1.83 post (T=9.5; p < .05). Patients in the 48 hour group also experienced significant reductions in vertigo intensity ratings, with a mean of 6.75 pre and 3.00 post (T = 0; p < .05).
A positive treatment outcome (operationally defined as either complete or partial recovery) was experienced by 92.1% (n = 70) of patients in the total group, including 95.4% (n = 63) of patients in the 24 hour group, and by 70.0% (n = 7) in the 48 hour posttreatment group (Table 4). In comparing each category of recovery, half of the entire sample (50.0%; n=38) experienced complete resolution of symptoms following treatment, 42.1% (n=32) had partial resolution, 3.9% (n=3) experienced no change, and 3.9% (n=3) had a worsening of symptoms. Further comparison of each category of recovery according to length of postural restrictions revealed that more than half (53.0%; n=35) of the patients in the 24 hour group had complete resolution compared to the 30.0% (n=3) in the 48 hour group.
The length of episode of care was also taken into consideration. The average episode of care was 35.32 days (SD 49.57) for the 24 hour group, and 47.25 days (SD 57.04) for the 48 hour group but this difference was not statistically significant.
The majority of patients in this retrospective review of records experienced positive treatment outcomes, with either complete or partial resolution of symptoms following repositioning maneuver for treatment of BPPV. This was evident by the significant decrease in the number of positive special tests, positive symptom provoking positions (including Dix-Hallpike), and intensity of vertigo from initial assessment to discharge. The results of this study suggest that both posttreatment options were effective in maintaining symptom resolution following a repositioning maneuver for patients with BPPV. Of particular clinical relevance was the finding that reducing the postural restriction time to 24 hours upright posttreatment did not adversely affect treatment outcomes. The large number of patients in this group supports the findings that positive treatment outcomes were achieved with less burdensome time frames for postural restriction posttreatment.
White et al18 noted that clinics continue to recommend post procedure postural restrictions based on anecdotal experience. Based on our results, continuing to advise patients to remain upright for 48 hours following a repositioning maneuver places an unnecessary burden on patients and cannot be justified. Our findings are of particular relevance given that 48 hour upright posttreatment instructions following a repositioning maneuver have been presented in research studies published as recently as 2006.25 Although noted in the literature and used by many clinics, lengthy postural restrictions place an unnecessary burden on patients who require treatment for BPPV. Our findings support previous authors28,30 who questioned the need for lengthy upright postural restrictions posttreatment. The results presented through this research support reducing the posttreatment instruction time by half, while still achieving positive treatment outcomes. By reducing the burden of maintaining an upright position for 48 hours, patients can return to activities of daily living quicker with the same symptom resolution. Moreover, a shorter time frame may also increase patient adherence to postural restrictions following the repositioning maneuver. Awareness of these findings is particularly important for therapists working with older adults, since older adults are at increased risk for BPPV16 and given the incidence and prevalence of this disorder among the elderly.1,7,8,13,14 Based on our results, therapists can reduce the length of postural restrictions following treatment without fear of adversely affecting outcomes.
The treatment outcomes experienced by patients in this sample fall within the range of treatment outcomes following repositioning maneuver reported in the literature. In the current sample, 53.0% of patients in the 24 hour group achieved complete symptom resolution while 50.0% of patients in the total group were asymptomatic at discharge. Several studies in the literature report complete resolution of symptoms following a single repositioning maneuver with recovery rates that range from 80% to 89%.7,11,26,28 However, earlier studies with smaller samples (n < 39) report fewer patients achieving symptom resolution following a single repositioning maneuver, ranging from 44% to 74%.20,29 In studies with large sample sizes exceeding 500 patients,5,26 the percentage of patients with symptom resolution was reported to be 67% to 84%. The smaller size of our sample may have influenced recovery rates. In some cases, outcomes were based solely on the conversion of a positive Dix-Hallpike test to a negative test following treatment,26 while other studies included patients with improvement in symptom status or a reduction in nystagmus.14,30 While not all of our patients experienced complete resolution, the vast majority had positive treatment outcomes achieving complete or partial symptom resolution. Blatt et al29 noted that postural difficulties persist for some patients with BPPV even after successful remission of vertigo and nystagmus, and these postural difficulties require further physical therapy interventions. This was true in the current sample as well. Stringent application of our recovery classification definitions meant that patients who had positive findings on special tests such as Romberg or tandem walking following CRM were categorized as having partial resolution, even when the Dix-Hallpike test results were negative. In addition, residual postural difficulties may have increased the length of the episode of care, particularly for patients in the current study with BPPV related to the co-morbidity of traumatic head injury.
Finally, our results are particularly promising for therapists who see patients in the outpatient setting without access to a balance or vestibular disorders specialty clinic. The findings have strong clinical utility, or practicality, for most therapists working with older adults since diagnosis and treatment were based on clinical tests, measures, and interventions accessible to all clinics. In a previous randomized trial, researchers22 relied upon clinical results of Dix-Hallpike testing as their inclusion criteria. All patients in the study also underwent bedside vestibular testing including oculomotor tests, positional tests, Romberg and tandem gait tests.
There were several limitations in this study that must be considered when examining the results. First, in this retrospective study the records of all patients in a cohort were reviewed and there was no mechanism to control sample distribution. As such, there were a greater number of patients who received 24 hour posttreatment instructions. The substantial difference in group sizes limited our ability to make direct comparisons to determine whether they were equally effective in producing positive treatment outcomes. Instead, pre- and postdata for each group was presented. A prospective study with random group assignment would lead to more equal distribution among the groups for comparison. The most that can be said is that both groups improved regardless of the length of postural restrictions issued in the post treatment guidelines.
A second limitation was that this study was completed at a single outpatient clinic. This potentially limits the degree to which the findings from this study can be generalized to the larger population of patients diagnosed with BPPV. However, the current sample of patients was similar to previous studies with respect to gender distribution (females > males)1,2,5,14,26,28 and age range,1,4,10,12,13,29 which enhances the credibility of our findings, particularly for the 24 hour group. Hilton and Pinder19 reported BPPV is twice as common in females, which is similar to our distribution.
Inconsistencies in documentation, a particular challenge for retrospective reviews of patient records, were noted. Missing data on the outcome measures of vertigo frequency and duration of provoked symptoms precluded analysis of these specific measures. At times, there was inconsistent collection of data regarding patients' symptoms. For example, for some patients, vertigo intensity was documented as mild/moderate/severe, instead of ratings on a 0–10 scale. As such, data analysis was limited to those outcome measures present in the majority of medical records. This contributed to the small number of patients in the 48 hour group with complete data for analysis.
Patient adherence to protocol was another extraneous variable for consideration. All patients received written copies of the posttreatment instructions, which was documented in the charts. However, there was no mechanism established for confirmation of patient adherence to their posttreatment instructions. In future studies, several strategies could address this. Follow-up by phone, having patients explain/demonstrate their protocol at next clinical visit, or recording their activities recording via a written log book could serve as mechanisms to confirm adherence to posttreatment instruction protocol.
Despite the limitations, the results of this study demonstrate that positive treatment outcomes were achieved for patients with BPPV when repositioning maneuver was used along with the 24 hour posttreatment instructions for upright postural restrictions. The high incidence of positive outcomes in the 24 hour group suggests that the lengthier 48 hour upright positioning is not needed. The implication for clinical practice is that therapists can reduce the time frame for postural restrictions following a repositioning maneuver without concerns of negatively impacting patient outcomes. The effectiveness of the 24 hour postural restrictions presents clinicians with treatment guidelines that are less burdensome and that could potentially increase patient adherence and satisfaction.
A prospective randomized, controlled study to assess the efficacy of posttreatment instructions for patients with BPPV should be considered for further study. Mechanisms to insure consistency of documentation and monitor protocol adherence should be implemented. Including standardized measures of perceived disability such as the Dizziness Handicap Inventory would also be recommended. In addition, a prospective study investigating the long-term outcomes and recurrence rates would be beneficial in assessing the overall efficacy of postural restrictions following repositioning maneuvers. While current findings support a reduction in the time frame for postural restrictions following treatment for BPPV, further study may determine whether therapists can eliminate postural restrictions all together following repositioning maneuvers. Eliminating the burden of postural restrictions would be particularly beneficial for older adults. Our second phase of investigation is an ongoing prospective study with patients randomly assigned to groups receiving posttreatment instructions of differing time frames, including no postural restrictions. Preliminary analysis suggests that patients may be able to return to usual activities following CRM, without need for any postural restrictions.31
The effectiveness of repositioning maneuvers in achieving resolution of symptoms associated with BPPV has been well established in the literature. The extent to which posttreatment postural restrictions impact outcomes is uncertain. In this retrospective study, maintaining an upright position for 24 hours following a repositioning maneuver produced positive treatment outcomes for patients. Continuing to advise patients to remain upright for 48 hours following a repositioning maneuver places an unnecessary burden on patients and cannot be justified. This information can significantly affect the quality of life for people with BPPV by reducing the burden of upright positioning and fostering a quicker return to their usual activities of daily living with the same positive outcome. These findings are of particular relevance to therapists working with older adults who are at increased risk for this disorder. We encourage therapists to offer posttreatment guidelines supported by evidence rather than anecdotal experience. Future randomized, controlled prospective studies are recommended to compare treatment outcomes for patients who observe postural restrictions for 24 hours vs. return to usual activities without postural restrictions.
This research was approved by the Institutional Review Board at Richard Stockton College of NJ and supported in part by Graduate Assistantships and a Distinguished Graduate Student Fellowship from the Office of Graduate Studies at Richard Stockton College of New Jersey. The authors also wish to acknowledge Michael Holmgren, Patrick Laliberte, Marius Hernandez, and Matthew Shohen for their assistance with data collection.
1. Cohen HS, Kimball KT. Effectiveness of treatments for benign paroxysmal positional vertigo of the posterior canal. Otol Neurol
2. Cohen H, Jerabek J. Efficacy of treatments for posterior canal benign paroxysmal positional vertigo. Laryngo.
3. Shubert MC. Vestibular disorders. In: O'Sullivan SB, Schmitz TJ. Physical Rehabilitation: Assessment and Treatment
. 5th ed. Philadelphia, PA: F.A. Davis Company; 2007:999-1030.
4. Sakaida M, Takeuchi K, Ischinaga M, Adachi M, Majima Y. Long term outcome of benign paroxysmal positional vertigo. Neurol
5. Steenerson RL, Cronin GW, Marbach PM. Effectiveness of treatment techniques in 923 cases of benign paroxysmal positional vertigo. Laryngo.
6. Sherman D, Massoud EAS. Treatment outcomes of BPPV. J Otolaryngol.
7. Salvinelli F, Trivelli M, Casale M, et.al. Treatment of benign paroxysmal positional vertigo in the elderly: a randomized trial. Am Laryngo Rhinol Otological Soc
8. Whitney SL, Marchetti GF, Morris LO. Usefulness of the dizziness handicap inventory in the screening for benign paroxysmal positional vertigo. Otol Neurol
. 2005;26:1027- 1033.
9. Imai T, Ito M, Takeda N, et al. Natural course of the remission of vertigo in patients with benign paroxysmal positional vertigo. Neurol
10. Baloh RW, Sloane PD, Honrubia V. Quantitative vestibular function testing in elderly patients with dizziness. Ear Nose Throat J
11. Richard W, Bruintjes T, Oostenbrink P, van Leeuwen RB. Efficacy of the Epley maneuver for posterior canal BPPV: a long-term controlled study of 81 patients. Ear Nose Throat J.
12. Nunez RA, Cass SP, Furman JM. Short- and long-term outcomes of canalith repositioning for benign paroxysmal positional vertigo. Otolaryngol Head Neck Surg,
13. Froeling DA, Silverstein MD, Mohr DN, Beatty CW, Offord KP, Ballard DJ. Benign positional vertigo: incidence and prognosis in a population-based study in Olmsted County, Minnesota. Mayo Clin Proc
14. Baloh RW, Honrubia V, Jacobson K. Benign positional vertigo: clinical and oculographic features in 240 cases. Neurol.
15. Herdman SJ, Tusa RJ. Physical therapy management of benign positional vertigo. In: Herdman SJ. Vestibular Rehabilitation
. 3rd ed. Philadelphia, PA. F. A. Davis Company; 2007: 228-260.
16. Parnes LS, Agrawal SK, Atlas J. Diagnosis and management of benign paroxysmal positional vertigo (BPPV). CMAJ
17. Oghali JS, Manolidis S, Stewart MG, Jenkins HA. Unrecognized benign paroxysmal positional vertigo in elderly patients. Otolaryngol Head Neck Surg.
18. White J, Savvides P, Cherian N, Oas J. Canalith repositioning for benign paroxysmal positional vertigo. Otol Neurol.
19. Hilton M, Pinder D. The Epley manoevere for benign paroxysmal positional vertigo - a systematic review. Clin Otolaryngol
20. Wolf M, Hertanu T, Novikov I, Kronenberb J. Epley's manuever for BPPV: a prospective study. Clin Otolaryngol
21. Tusa RJ. BPPV: controlled trials, contraindications and post-treatment instructions, complications, imbalance. Audiol Med
22. Asawavichianginda S, Isipradit P, Snidvongs K, Supiyaphun P. Canalith repositioning for benign paroxysmal vertigo: a randomized, controlled trial. Ear Nose Throat J
23. Yimtae K, Srirompotong S, et.al. A Randomized trial of the canalith repositioning procedure. Laryngo
. 2003;113:828- 832.
24. Tzagournissakis M, Prokopakis E, Cheimona T, Erimaki S, Velegrakis G. Canalith repositioning procedure is an effective treatment for benign paroxysmal positional vertigo: long term results in 460 patients. Neurol
25. Hilton M, Pinder D. The Epley (canalith repositioning) manoeuvre for benign paroxysmal positional vertigo. Cochrane Database of Systematic Reviews
26. Prokopakis E, Chimona T, Tsagournisakis M, et al. Benign paroxysmal positional vertigo: 10 year experience in treating 592 patients with canalith repositioning procedure. Laryngo
. 2005; 115:1667-1671.
27. Froeling DA, Bowen JM, Mohr DN, et al. The Canalith repositioning procedure for treatment of benign paroxysmal positional vertigo: a randomized control trial. Mayo Clinic
28 Roberts RA, Gans RE, DeBoodt JL, Lister JJ. Treatment of benign paroxysmal positional vertigo: necessity of postmaneuver patient restrictions. J Am Acad Audiol
29. Blatt PJ, Georgakakis GA, Herdman SJ, Clendaniel RA, Tusa RJ. The effect of the canalith repositioning maneuver on resolving postural instability in patients with benign paroxysmal positional vertigo. Am J Otology.
30. Moon S, Bae SH, Kim HD, Kim JH, Co YB. The effect of postural restrictions in the treatment of benign paroxysmal positional vertigo. Eur Arch Otorhinolaryngol.
31. McGinnis PQ, Nebbia M, Rudolph K, Colletti A, Saez L, Brown K. Efficacy of post-treatment instructions in patients with benign paroxysmal positional vertigo. J Geriatr Phys Ther.
Keywords:Copyright © 2009 the Section on Geriatrics of the American Physical Therapy Association
benign paroxysmal positional vertigo (BPPV); dizziness; postural restrictions